Henry Buchwald, MD, PhD, FACS, Hon FRCS (Eng) is Professor of Surgery and Biomedical Engineering and the Owen H. and Sarah Davidson Wangensteen Chair in Experimental Surgery Emeritus at the University of Minnesota. Dr. Buchwald attended Columbia College and the College of Physicians Surgeons of Columbia University. He was the Principal Investigator of the twenty-year Program on the Surgical Control of the Hyperlipidemias, the first randomized clinical trial to demonstrate that cholesterol lowering by his partial ileal bypass operation resulted in reductions in cardiovascular disease and prolonged life expectancy. Buchwald was a pioneer in bariatric surgery and the coauthor and primary advocate of the concept of metabolic surgery. He holds 20 patents for bioengineering devices, including the first implantable infusion pump used in insulin delivery and continuous chemotherapy delivery. Buchwald is the author of over360 peer-reviewed medical publications and more than 100 book chapters and books. He has served as Editor-in-Chief of the journal Obesity Surgery and writes a bi-monthly column for General Surgery News. The past president of five surgical organizations, Buchwald is the recipient of numerous awards and honors in recognition of his clinical and scholarly accomplishments, including the American College of Surgeons Jacobson Innovation Award (2019) and the Vagelos College of Physicians and Surgeons gold medal for achievement in research (2020). He lives with his wife, Emilie Buchwald, in Minneapolis.
